Valuation
- Market cap
- 375,689,000
- Revenue TTM
- $50,510,000
- Net income TTM
- $-29,630,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -58.66%
- Debt to equity
- 0.18
Trading
- Volume
- 151,600
- Avg volume
- 123,952
- Day's range
- $13.70 – $14.61
- Shares out
- 27,303,000
- Stochastic %K
- 34%
- Beta
- 2.10
- Analysts
- Strong Sell
- Price target
- $18.67
Company profile
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-buil...
Show more
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 760 766 1923
- Website
- https://carlsmed.com
- Address
- 1800 Aston Avenue, Suite 100, Carlsbad, United States
Latest news
No headlines yet.
